
Sean M. Basquill
Examiner (ID: 6963, Phone: (571)270-5862 , Office: P/1613 )
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1612, 1614, 1613 |
| Total Applications | 1332 |
| Issued Applications | 496 |
| Pending Applications | 114 |
| Abandoned Applications | 739 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20756281
[patent_doc_number] => 12649031
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-09
[patent_title] => Methods for delivering agents with pre-filled syringes to minimize intraocular inflammation
[patent_app_type] => utility
[patent_app_number] => 17/930373
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 95
[patent_figures_cnt] => 231
[patent_no_of_words] => 49001
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930373
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930373 | Methods for delivering agents with pre-filled syringes to minimize intraocular inflammation | Sep 6, 2022 | Issued |
Array
(
[id] => 19989290
[patent_doc_number] => 20250127512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => SYSTEMS AND METHODS FOR STIMULATION, NERVE REPAIR AND/OR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/688218
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18688218
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/688218 | SYSTEMS AND METHODS FOR STIMULATION, NERVE REPAIR AND/OR DRUG DELIVERY | Sep 1, 2022 | Pending |
Array
(
[id] => 18170386
[patent_doc_number] => 20230036997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => COMBINATION OF POLYETHYLENE GLYCOL AND RAPAMYCIN AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/901108
[patent_app_country] => US
[patent_app_date] => 2022-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17901108
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/901108 | COMBINATION OF POLYETHYLENE GLYCOL AND RAPAMYCIN AND USE THEREOF | Aug 31, 2022 | Abandoned |
Array
(
[id] => 19988952
[patent_doc_number] => 20250127174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => FORMULATIONS FOR ANTIMICROBIAL THERMOSET COATINGS
[patent_app_type] => utility
[patent_app_number] => 18/687557
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18687557
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/687557 | FORMULATIONS FOR ANTIMICROBIAL THERMOSET COATINGS | Aug 29, 2022 | Pending |
Array
(
[id] => 18250597
[patent_doc_number] => 20230077636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => INTRAVENOUS FORMULATIONS OF RK-33
[patent_app_type] => utility
[patent_app_number] => 17/822922
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822922
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822922 | Intravenous formulations of RK-33 | Aug 28, 2022 | Issued |
Array
(
[id] => 20106973
[patent_doc_number] => 12357671
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => Compositions and methods for invasive and non-invasive procedural skincare
[patent_app_type] => utility
[patent_app_number] => 17/898223
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 47
[patent_no_of_words] => 22493
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898223
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/898223 | Compositions and methods for invasive and non-invasive procedural skincare | Aug 28, 2022 | Issued |
Array
(
[id] => 18109519
[patent_doc_number] => 20230002399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => LONG-ACTING INJECTABLE FORMULATIONS AND CRYSTALLINE FORMS OF BUPRENORPHINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/896280
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17896280
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/896280 | Long-acting injectable formulations and crystalline forms of buprenorphine derivatives | Aug 25, 2022 | Issued |
Array
(
[id] => 18323403
[patent_doc_number] => 20230121531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => TRIPULSE RELEASE STIMULANT FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/822226
[patent_app_country] => US
[patent_app_date] => 2022-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822226
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822226 | TRIPULSE RELEASE STIMULANT FORMULATIONS | Aug 24, 2022 | Abandoned |
Array
(
[id] => 18443528
[patent_doc_number] => 11679079
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-06-20
[patent_title] => Ophthalmic formulations and related methods
[patent_app_type] => utility
[patent_app_number] => 17/895513
[patent_app_country] => US
[patent_app_date] => 2022-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19003
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17895513
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/895513 | Ophthalmic formulations and related methods | Aug 24, 2022 | Issued |
Array
(
[id] => 20218697
[patent_doc_number] => 20250281628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => COMPOSITE NANOPARTICULATE MINERALIZED COLLAGEN GLYCOSAMINOGLYCAN MATERIALS WITH TIME RELEASE ANTI-RESORPTIVE FACTORS
[patent_app_type] => utility
[patent_app_number] => 18/685853
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24973
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18685853
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/685853 | COMPOSITE NANOPARTICULATE MINERALIZED COLLAGEN GLYCOSAMINOGLYCAN MATERIALS WITH TIME RELEASE ANTI-RESORPTIVE FACTORS | Aug 22, 2022 | Pending |
Array
(
[id] => 18995972
[patent_doc_number] => 11912800
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Amide-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses
[patent_app_type] => utility
[patent_app_number] => 17/821315
[patent_app_country] => US
[patent_app_date] => 2022-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17490
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821315
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821315 | Amide-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses | Aug 21, 2022 | Issued |
Array
(
[id] => 18075744
[patent_doc_number] => 20220401356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => INTRACAMERAL DRUG DELIVERY DEPOTS
[patent_app_type] => utility
[patent_app_number] => 17/890997
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/890997 | INTRACAMERAL DRUG DELIVERY DEPOTS | Aug 17, 2022 | Abandoned |
Array
(
[id] => 18239003
[patent_doc_number] => 20230071314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => POLYMERIC COMPOSITIONS FOR SUSTAINED DELIVERY OF VMAT2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/889009
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17889009
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/889009 | POLYMERIC COMPOSITIONS FOR SUSTAINED DELIVERY OF VMAT2 INHIBITORS | Aug 15, 2022 | Abandoned |
Array
(
[id] => 18495998
[patent_doc_number] => 20230218523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents
[patent_app_type] => utility
[patent_app_number] => 17/887934
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17887934
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/887934 | Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents | Aug 14, 2022 | Abandoned |
Array
(
[id] => 19989503
[patent_doc_number] => 20250127725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => MAGNESIUM OXIDE TABLETS
[patent_app_type] => utility
[patent_app_number] => 18/685051
[patent_app_country] => US
[patent_app_date] => 2022-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18685051
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/685051 | MAGNESIUM OXIDE TABLETS | Aug 8, 2022 | Pending |
Array
(
[id] => 18938177
[patent_doc_number] => 20240033316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => SELF-ASSEMBLED NANOPARTICLE AND USE THEREOF FOR ANTI- ANGIOGENESIS
[patent_app_type] => utility
[patent_app_number] => 17/815195
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815195
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/815195 | Self-assembled nanoparticle and use thereof for anti-angiogenesis | Jul 25, 2022 | Issued |
Array
(
[id] => 19656818
[patent_doc_number] => 20240423883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => COMPOSITION FOR LIGHTENING KERATIN FIBRES, COMPRISING A PEROXYGENATED SALT, CARBONATE AND/OR AMMONIUM BICARBONATE AND AT LEAST 1% OF A POLYPHOSPHORUS DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 18/292286
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6643
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18292286
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/292286 | COMPOSITION FOR LIGHTENING KERATIN FIBRES, COMPRISING A PEROXYGENATED SALT, CARBONATE AND/OR AMMONIUM BICARBONATE AND AT LEAST 1% OF A POLYPHOSPHORUS DERIVATIVE | Jul 25, 2022 | Pending |
Array
(
[id] => 18418490
[patent_doc_number] => 20230172948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => OCULAR IMPLANT MADE BY A DOUBLE EXTRUSION PROCES
[patent_app_type] => utility
[patent_app_number] => 17/812133
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812133 | OCULAR IMPLANT MADE BY A DOUBLE EXTRUSION PROCES | Jul 11, 2022 | Abandoned |
Array
(
[id] => 18383206
[patent_doc_number] => 11653969
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Methods of alleviating symptoms of ocular surface discomfort using medical ice slurry
[patent_app_type] => utility
[patent_app_number] => 17/839674
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 9675
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839674 | Methods of alleviating symptoms of ocular surface discomfort using medical ice slurry | Jun 13, 2022 | Issued |
Array
(
[id] => 17895380
[patent_doc_number] => 20220305042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => Drug Delivery Composition Comprising a Self-Assembled Gelator
[patent_app_type] => utility
[patent_app_number] => 17/839851
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839851
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839851 | Drug Delivery Composition Comprising a Self-Assembled Gelator | Jun 13, 2022 | Abandoned |